Bristol Myers Squibb EBITDA 2010-2025 | BMY

Bristol Myers Squibb EBITDA for the quarter ending March 31, 2025 was $3.982B, a 144.32% decline year-over-year.

  • Bristol Myers Squibb 2024 EBITDA was 1.221B, a 93.29% decline from 2023.
  • Bristol Myers Squibb 2023 EBITDA was 18.2B, a 1.17% increase from 2022.
  • Bristol Myers Squibb 2022 EBITDA was 17.989B, a 4.23% decline from 2021.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.

Bristol Myers Squibb EBITDA 2010-2025 | BMY

  • Bristol Myers Squibb 2024 EBITDA was 1.221B, a 93.29% decline from 2023.
  • Bristol Myers Squibb 2023 EBITDA was 18.2B, a 1.17% increase from 2022.
  • Bristol Myers Squibb 2022 EBITDA was 17.989B, a 4.23% decline from 2021.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.